• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nationwide Recall: Pfizer Lo/Ovral-28 and Norgestrel/Ethinyl Estradiol Tablets - Inexact Count of Inert or Active Ingredient Tablets

Missouriwatcher

Editor, Senior Moderator
January 31, 2012 - NEW YORK, N.Y. ? Pfizer Inc. announced today that it has voluntarily recalled 14 lots of Lo/Ovral-28 (norgestrel and ethinyl estradiol)Tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic) for customers in the U.S. market. An investigation by Pfizer found that some blister packs may contain an inexact count of inert or active ingredient tablets and that the tablets may be out of sequence. The cause was identified and corrected immediately.

These products are oral contraceptives indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. These tablets were manufactured and packaged by Pfizer Inc., commercialized by Akrimax Rx Products and labeled under the Akrimax Pharmaceuticals brand. This product is distributed to warehouses, clinics and retail pharmacies nationwide.

As a result of this packaging error, the daily regimen for these oral contraceptives may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy. These packaging defects do not pose any immediate health risks. However, consumers exposed to affected packaging should begin using a non-hormonal form of contraception immediately. Patients who have the affected product (lot numbers are provided below) should notify their physician and return the product to the pharmacy.

These products are packaged in blister packs containing 21 tablets of active ingredients and seven tablets of inert ingredients. Correct dosing of this product is important in avoiding the associated risks of an unplanned pregnancy...

NDC Product Lot Expiration Configuration/Count
24090-801-84 LO/OVRAL? 28 E15678 08/31/2013 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 E15679 08/31/2013 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 E15686 08/31/2013 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 E15687 01/31/2014 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 E15690 01/31/2014 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 E15698 01/31/2014 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 E15700 02/28/2014 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 E80434 07/31/2013 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 E80438 08/31/2013 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 F36908 02/28/2014 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 F36909 02/28/2014 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 F43915 03/31/2014 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 F43926 03/31/2014 6 Pilpacks? of 28 tablets each
24090-801-84 LO/OVRAL? 28 F43927 03/31/2014 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg E15677 08/31/2013 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg E15704 01/31/2014 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg E15706 01/31/2014 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg E80440 08/31/2013 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg F16388 01/31/2014 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg F16390 02/28/2014 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg F22132 02/28/2014 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg F31330 02/28/2014 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg F36911 03/31/2014 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg F36913 03/31/2014 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg F43924 03/31/2014 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg F43925 03/31/2014 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg F43934 03/31/2014 6 Pilpacks? of 28 tablets each
24090-961-84 Norgestrel 0.3 mg/Ethinyl Estradiol 0.03 mg F53238 03/31/2014 6 Pilpacks? of 28 tablets each
http://www.fda.gov/Safety/Recalls/ucm289770.htm
 
Back
Top Bottom